Cartesian Therapeutics, Inc. financial data

Symbol
RNAC on Nasdaq
Location
Frederick, MD
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.11K % +205%
Debt-to-equity -2.5K % -818%
Return On Equity 287 % +92.5%
Return On Assets -12 % +82.5%
Operating Margin -8.39K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26M shares +2.32%
Common Stock, Shares, Outstanding 26M shares +8.82%
Entity Public Float 194M USD +50.5%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 26M shares +21.1%
Weighted Average Number of Shares Outstanding, Diluted 26M shares +21.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.09M USD +16.8%
Revenue from Contract with Customer, Excluding Assessed Tax -436K USD -101%
Research and Development Expense 54.7M USD -1.8%
General and Administrative Expense 30.4M USD -32.7%
Operating Income (Loss) -91.5M USD -71%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9M USD -9.59%
Net Income (Loss) Attributable to Parent -48M USD +80.4%
Earnings Per Share, Basic 5 USD/shares -22.1%
Earnings Per Share, Diluted 5 USD/shares -22.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 143M USD -34.6%
Accounts Receivable, after Allowance for Credit Loss, Current 722K USD -85%
Assets, Current 147M USD -35.7%
Property, Plant and Equipment, Net 12.4M USD +21.2%
Operating Lease, Right-of-Use Asset 4.97M USD -63.2%
Goodwill 48.2M USD 0%
Other Assets, Noncurrent 5.55M USD
Assets 373M USD -18.2%
Accounts Payable, Current 2.23M USD +330%
Employee-related Liabilities, Current 3.06M USD +72.1%
Accrued Liabilities, Current 7.7M USD -17.7%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 13.8M USD -35.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 16.1M USD +1.82%
Operating Lease, Liability, Noncurrent 8.73M USD -26.5%
Liabilities 409M USD -10.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -4.59M USD +0.41%
Retained Earnings (Accumulated Deficit) -730M USD -7.04%
Stockholders' Equity Attributable to Parent -35.8M USD -4866%
Liabilities and Equity 373M USD -18.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.1M USD -45.2%
Net Cash Provided by (Used in) Financing Activities -8.03M USD -119%
Net Cash Provided by (Used in) Investing Activities -1.08M USD -78.6%
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 26M shares +8.82%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -32.2M USD -221%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 145M USD -34.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 248M USD +99.4%
Deferred Tax Assets, Gross 275M USD +80.2%
Operating Lease, Liability 12.6M USD -14%
Depreciation 2.3M USD +156%
Payments to Acquire Property, Plant, and Equipment 1.08M USD +78.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -48M USD +80.4%
Lessee, Operating Lease, Liability, to be Paid 15.9M USD -18.5%
Property, Plant and Equipment, Gross 16.5M USD -0.12%
Operating Lease, Liability, Current 3.88M USD +39.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.35M USD -4.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.54M USD +2.79%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.31M USD -32.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.31M USD -46.7%
Deferred Tax Assets, Operating Loss Carryforwards 44.1M USD +47.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 9.43M shares +0.49%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.41M USD -39.1%
Operating Lease, Payments 317K USD -58.3%
Additional Paid in Capital 699M USD +1.65%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 10.2M USD -53.7%
Interest Expense 2.03M USD -35.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%